By Mardi Chapman for the Limbic, 2018Gout is common for patients with end stage kidney disease and dialysis provides an extra challenge for providing effective urate lowering therapy (ULT) in this group of patients.
A retrospective New Zealand study of more than 200 dialysis patients found more than a quarter (28.2%) of the patients had gout.
Click here, to read the full Limbic article
Click here, to view the referenced study by Yeo, et al. (2018)